Skip to main content
You have permission to edit this article.
Edit
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vistagen Therap. Com (NQ: VTGN )

0.1640 +0.0012 (+0.74%)
Streaming Delayed Price Updated: 1:16 PM EDT, Oct 5, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,621,737
Open 0.1645
Bid (Size) 0.1628 (13)
Ask (Size) 0.1640 (1)
Prev. Close 0.1628
Today's Range 0.1542 - 0.1649
52wk Range 0.1388 - 2.780
Shares Outstanding 206,836,345
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
InvestorNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN) CEO to Participate at Cantor Neurology & Psychiatry Conference
Via Investor Brand Network
Vistagen to Participate at Cantor Neurology & Psychiatry Conference
From Vistagen
Via Business Wire

Performance

YTD
-92.15%
-92.15%
1 Month
-1.91%
-1.91%
3 Month
-81.26%
-81.26%
6 Month
-86.33%
-86.33%
1 Year
-93.88%
-93.88%

More News

Read More
Why ECMOHO Is Trading Lower By 29%; Here Are 28 Stocks Moving Premarket
Via Benzinga
Independent Biostatisticians Recommend Vistagen Continue Late-Stage Anxiety Trial
Via Benzinga
Earnings Scheduled For August 11, 2022
Via Benzinga
Vistagen CEO Shawn Singh to Join Executive Roundtable Discussing Mental Health at Concordia Annual Summit
From Vistagen
Via Business Wire
Vistagen Presents Poster at Psych Congress 2022 Highlighting Effect of PH94B on Nasal Electrogram Responses and Biomarkers of Autonomic Nervous System Activity in Healthy Human Subjects
From Vistagen
Via Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why SciSparc Is Trading Higher By 68%, Here Are 48 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
InvestorNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN) Announces Participation Schedule for Upcoming Conferences
Via Investor Brand Network
Vistagen to Participate in Upcoming Morgan Stanley and Baird Healthcare Conferences
From Vistagen Therapeutics, Inc.
Via Business Wire
Why Zumiez Is Trading Lower By 14%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why ShiftPixy Surged Around 177%; Here Are 71 Biggest Movers From Yesterday
Via Benzinga
Important Biotech Catalysts For September 8, 2022 - End Of The Day Summary
Via Benzinga
InvestorNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN) to Report FY 2023 Q1 Results, Host Conference Call and Webcast
Via Investor Brand Network
Vistagen to Proceed with PALISADE-2 Phase 3 Clinical Trial of PH94B in Social Anxiety Disorder following Interim Analysis
From Vistagen Therapeutics, Inc.
Via Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Why Bed Bath & Beyond Is Trading Lower By Over 40%, Here Are 55 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Crypto-Related Stocks Are Trading Lower: Here Are 34 Stocks Moving Premarket
Via Benzinga
InvestorNewsBreaks — VistaGen Therapeutics Inc. (NASDAQ: VTGN) Releases Q1 2023 Financial, Corporate Report
Via Investor Brand Network
Exposures Product Safety
This Healthcare Stock Dipped Over 30%; Here Are 83 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
VistaGen Therapeutics Reports First Quarter Financial Results and Provides Corporate Update
From VistaGen Therapeutics, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.